Patent details

Herbas

VPB

Print

EN | LT

LT - USE OF GLP-1, EXENDIN AND AGONISTS THEREOF TO DELAY OR PREVENT CARDIAC REMODELING

EN - USE OF GLP-1, EXENDIN AND AGONISTS THEREOF TO DELAY OR PREVENT CARDIAC REMODELING

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 38/22
		A61K 38/26
		A61P 9/00

European patent
(11)	Number of the document	1888103
(13)	Kind of document	T
(96)	European patent application number	06740942.5
	Date of filing the European patent application	2006-04-11
(97)	Date of publication of the European application	2008-02-20
(45)	Date of publication and mention of the grant of the patent	2012-03-21
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/US2006/013949
	Date	2006-04-11

PCT application publication
(87)	Number	WO 2006/110887
	Date	2006-10-19

Priority applications
(30)	Number	Date	Country code
	669876 P	2005-04-11	US

Inventors
(72)	ANDERSON, Christen, US LIU, Que, US

Grantee
(73)	AMYLIN PHARMACEUTICALS, INC., 9360 Towne Centre Drive, San Diego, CA 92121, US

Title
(54)	USE OF GLP-1, EXENDIN AND AGONISTS THEREOF TO DELAY OR PREVENT CARDIAC REMODELING
	USE OF GLP-1, EXENDIN AND AGONISTS THEREOF TO DELAY OR PREVENT CARDIAC REMODELING